RU2013148719A - COMPOSITION BASED ON MAGNESIUM CHLORIDE HYDROXOALUMINATE, CONTAINING MAGNESIUM HYDROXIDE, AS A THERAPEUTIC DRUG - Google Patents

COMPOSITION BASED ON MAGNESIUM CHLORIDE HYDROXOALUMINATE, CONTAINING MAGNESIUM HYDROXIDE, AS A THERAPEUTIC DRUG Download PDF

Info

Publication number
RU2013148719A
RU2013148719A RU2013148719/15A RU2013148719A RU2013148719A RU 2013148719 A RU2013148719 A RU 2013148719A RU 2013148719/15 A RU2013148719/15 A RU 2013148719/15A RU 2013148719 A RU2013148719 A RU 2013148719A RU 2013148719 A RU2013148719 A RU 2013148719A
Authority
RU
Russia
Prior art keywords
hydroxoaluminate
magnesium hydroxide
composition based
magnesium chloride
magnesium
Prior art date
Application number
RU2013148719/15A
Other languages
Russian (ru)
Inventor
Геннадий Гильфанович Галимов
Original Assignee
Геннадий Гильфанович Галимов
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Геннадий Гильфанович Галимов filed Critical Геннадий Гильфанович Галимов
Priority to RU2013148719/15A priority Critical patent/RU2013148719A/en
Priority to DE201320011755 priority patent/DE202013011755U1/en
Priority to DE102013113676.1A priority patent/DE102013113676A1/en
Publication of RU2013148719A publication Critical patent/RU2013148719A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A61K33/08—Oxides; Hydroxides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

1. Композиция на основе гидроксоалюмината хлорида магния, содержащая гидроксид магния, в качестве терапевтического препарата, отличающаяся тем, что, с целью увеличения длительности взаимодействия ее с желудочным соком, гидроксоалюминат хлорид магния с 0,1-0,9 процентами гидроксида магния берут с удельной поверхностью 20-150 м/г и насыпной плотностью 0,4-1,0 г/мпри следующем соотношении компонентов, мас.%:2. Композиция на основе гидроксоалюмината хлорида магния, содержащая гидроксид магния, в качестве терапевтического препарата по п.1, отличающаяся тем, что ее берут в виде конгломератов ультрадисперсных кристаллов размерами 0,01-1000 мкм.3. Композиция на основе гидроксоалюмината хлорида магния, содержащая гидроксид магния, в качестве терапевтического препарата по п.1, отличающаяся тем, что она содержит гидроксид магния в химически соосажденном виде.4. Композиция на основе гидроксоалюмината хлорида магния, содержащая гидроксид магния, в качестве терапевтического препарата по п.1, отличающаяся тем, что она содержит гидроксид магния в виде механической смеси.1. A composition based on magnesium chloride hydroxoaluminate containing magnesium hydroxide as a therapeutic drug, characterized in that, in order to increase the duration of its interaction with gastric juice, magnesium chloride hydroxoaluminate with 0.1-0.9 percent magnesium hydroxide is taken with a specific a surface of 20-150 m / g and a bulk density of 0.4-1.0 g / m in the following ratio of components, wt.%: 2. A composition based on magnesium chloride hydroxoaluminate containing magnesium hydroxide as a therapeutic preparation according to claim 1, characterized in that it is taken in the form of conglomerates of ultrafine crystals with sizes of 0.01-1000 μm. A composition based on magnesium chloride hydroxoaluminate containing magnesium hydroxide as a therapeutic preparation according to claim 1, characterized in that it contains magnesium hydroxide in a chemically precipitated form. A composition based on magnesium chloride hydroxoaluminate containing magnesium hydroxide as a therapeutic preparation according to claim 1, characterized in that it contains magnesium hydroxide in the form of a mechanical mixture.

Claims (4)

1. Композиция на основе гидроксоалюмината хлорида магния, содержащая гидроксид магния, в качестве терапевтического препарата, отличающаяся тем, что, с целью увеличения длительности взаимодействия ее с желудочным соком, гидроксоалюминат хлорид магния с 0,1-0,9 процентами гидроксида магния берут с удельной поверхностью 20-150 м2/г и насыпной плотностью 0,4-1,0 г/м3 при следующем соотношении компонентов, мас.%:1. A composition based on magnesium chloride hydroxoaluminate containing magnesium hydroxide as a therapeutic drug, characterized in that, in order to increase the duration of its interaction with gastric juice, magnesium chloride hydroxoaluminate with 0.1-0.9 percent magnesium hydroxide is taken with a specific a surface of 20-150 m 2 / g and a bulk density of 0.4-1.0 g / m 3 in the following ratio of components, wt.%: Гидроксид магнияMagnesium hydroxide   Mg(OH)2 Mg (OH) 2 0,1-0,90.1-0.9 Гидроксоалюминат хлорид магнияHydroxoaluminate Magnesium Chloride   5Mg(OH)2∙MgCl2∙2Al(OH)3∙4H2O5Mg (OH) 2 ∙ MgCl 2 ∙ 2Al (OH) 3 ∙ 4H 2 O ОстальноеRest
2. Композиция на основе гидроксоалюмината хлорида магния, содержащая гидроксид магния, в качестве терапевтического препарата по п.1, отличающаяся тем, что ее берут в виде конгломератов ультрадисперсных кристаллов размерами 0,01-1000 мкм.2. A composition based on magnesium chloride hydroxoaluminate containing magnesium hydroxide as a therapeutic preparation according to claim 1, characterized in that it is taken in the form of conglomerates of ultrafine crystals with sizes of 0.01-1000 μm. 3. Композиция на основе гидроксоалюмината хлорида магния, содержащая гидроксид магния, в качестве терапевтического препарата по п.1, отличающаяся тем, что она содержит гидроксид магния в химически соосажденном виде.3. A composition based on magnesium chloride hydroxoaluminate containing magnesium hydroxide as a therapeutic preparation according to claim 1, characterized in that it contains magnesium hydroxide in a chemically precipitated form. 4. Композиция на основе гидроксоалюмината хлорида магния, содержащая гидроксид магния, в качестве терапевтического препарата по п.1, отличающаяся тем, что она содержит гидроксид магния в виде механической смеси. 4. A composition based on magnesium chloride hydroxoaluminate containing magnesium hydroxide as a therapeutic preparation according to claim 1, characterized in that it contains magnesium hydroxide in the form of a mechanical mixture.
RU2013148719/15A 2013-10-31 2013-10-31 COMPOSITION BASED ON MAGNESIUM CHLORIDE HYDROXOALUMINATE, CONTAINING MAGNESIUM HYDROXIDE, AS A THERAPEUTIC DRUG RU2013148719A (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
RU2013148719/15A RU2013148719A (en) 2013-10-31 2013-10-31 COMPOSITION BASED ON MAGNESIUM CHLORIDE HYDROXOALUMINATE, CONTAINING MAGNESIUM HYDROXIDE, AS A THERAPEUTIC DRUG
DE201320011755 DE202013011755U1 (en) 2013-10-31 2013-12-09 Magnesium chloride hydroxoaluminate preparation with magnesium hydroxide as a therapeutic preparation
DE102013113676.1A DE102013113676A1 (en) 2013-10-31 2013-12-09 Magnesium chloride hydroxoaluminate preparation with magnesium hydroxide as a therapeutic preparation

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
RU2013148719/15A RU2013148719A (en) 2013-10-31 2013-10-31 COMPOSITION BASED ON MAGNESIUM CHLORIDE HYDROXOALUMINATE, CONTAINING MAGNESIUM HYDROXIDE, AS A THERAPEUTIC DRUG

Publications (1)

Publication Number Publication Date
RU2013148719A true RU2013148719A (en) 2015-05-10

Family

ID=51206325

Family Applications (1)

Application Number Title Priority Date Filing Date
RU2013148719/15A RU2013148719A (en) 2013-10-31 2013-10-31 COMPOSITION BASED ON MAGNESIUM CHLORIDE HYDROXOALUMINATE, CONTAINING MAGNESIUM HYDROXIDE, AS A THERAPEUTIC DRUG

Country Status (2)

Country Link
DE (2) DE102013113676A1 (en)
RU (1) RU2013148719A (en)

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH02111625A (en) * 1988-10-20 1990-04-24 Kyowa Chem Ind Co Ltd High-activity, high-dispersibility magnesium hydroxide and its production
WO1994013304A2 (en) * 1992-12-11 1994-06-23 Eastman Kodak Company Antacid composition and method of production
TW397686B (en) * 1993-08-11 2000-07-11 Takeda Chemical Industries Ltd Antacid compositions and pharmaceutical compositions
DE4444052A1 (en) * 1994-12-10 1996-06-13 Rhone Poulenc Rorer Gmbh Pharmaceutical, oral preparation
RU2359913C1 (en) * 2008-02-08 2009-06-27 Геннадий Гильфанович Галимов Substance on basis of magnesium hydroxoaluminate, containing coprecipitated aluminium hydroxide, and way of its obtaining
RU2392225C2 (en) * 2008-07-04 2010-06-20 Геннадий Гильфанович Галимов Composition of magnesium hydroxoluminate and aluminium hydroxide and method of obtainment thereof
RU2464227C1 (en) 2011-04-21 2012-10-20 Геннадий Гильфанович Галимов Magnesium chloride hydroxoaluminate-based composition containing magnesium hydroxide as therapeutic preparation
CN103303949B (en) * 2013-05-23 2014-12-31 北京化工大学 Vegetable-sponge-shaped hydrotalcite-like compound and preparation method thereof

Also Published As

Publication number Publication date
DE102013113676A1 (en) 2015-04-30
DE202013011755U1 (en) 2014-07-01

Similar Documents

Publication Publication Date Title
MX2018003975A (en) Combination of glycosaminoglycans and an antacid agent and compositions thereof.
AR102781A1 (en) PHARMACEUTICAL COMPOSITION THAT COMBINES AT LEAST TWO DIFFERENT NANOPARTICLES AND A PHARMACEUTICAL COMPOUND, ITS PREPARATION AND ITS USES
RU2013148719A (en) COMPOSITION BASED ON MAGNESIUM CHLORIDE HYDROXOALUMINATE, CONTAINING MAGNESIUM HYDROXIDE, AS A THERAPEUTIC DRUG
RU2013136962A (en) REPAIR AND INSULATION, TUMPING COMPOSITION BASED ON MAGNESIA BINDERS "QUICK-STONE"
RU2011108190A (en) GYPSUM MIXTURE FOR PRODUCTION OF CONSTRUCTION PRODUCTS
EA201592297A1 (en) AGOMELATIN COMPOSITIONS CONTAINING AGOMELATIN IN THE FORM OF CRYSTALS
RU2013121928A (en) Grouting mortar
RU2010144473A (en) TUMPING MATERIAL FOR CEMENTING CASING COLUMNS AND METHOD FOR PREPARING IT
RU2013101700A (en) GYPSOMAGNESIUM TUMPING SOLUTION
RU2012136939A (en) TOILET SOAP
RU2017117990A (en) MAGNESIUM TUMPING MATERIAL
RU2012142522A (en) OLIGOETOXYSILOXAN (OPTIONS)
RU2012120349A (en) DEGASING-REFINING MIXTURE WITH MODIFICATING EFFECT
EA201790754A1 (en) ANTI-PERSPIRENT COMPOSITIONS CONTAINING SAGGES
RU2010138540A (en) COMPOSITION HAVING CAPILLARY PROTECTIVE ACTIVITY BASED ON DIHYDROQUERCETETINE AND METHOD FOR PRODUCING IT
RU2012117090A (en) COMPLEX BINDER
RU2011118793A (en) PORTLAND CEMENT MIXTURE WITH MINERAL ADDITIVE
RU2013101186A (en) LAMPING LIGHTED SULFUR CONTAINING SOLUTION
RU2012112567A (en) MORTGAGE MIXTURE
RU2014134077A (en) SLIPER FOR CERAMIC PRODUCTION
RU2013101805A (en) MEANS FOR PREPARING SOLUTION FOR EXTERNAL USE
RU2011103506A (en) MIXTURE FOR Cordierite Ceramics
RU2013143065A (en) ANTI-ICE PRODUCT
RU2012111792A (en) PLASTIC FILLER FOR MIXTURES BASED ON CEMENT BINDERS
RU2013112317A (en) COMPOSITION OF MORTGAGE MIXTURE

Legal Events

Date Code Title Description
FA93 Acknowledgement of application withdrawn (no request for examination)

Effective date: 20161101